L Jeffrey Medeiros Selected Research

L Jeffrey Medeiros Research Topics

Disease

196	Neoplasms (Cancer) 03/2024 - 02/2002
96	Lymphoma (Lymphomas) 12/2023 - 02/2002
67	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2024 - 05/2002
54	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 06/2002
51	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 02/2004
41	Hodgkin Disease (Hodgkin's Disease) 07/2023 - 02/2002
38	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 05/2002
35	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 11/2002
29	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2023 - 05/2002
27	Disease Progression 12/2023 - 01/2007
27	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 10/2007
23	T-Cell Lymphoma (Lymphoma, T Cell) 02/2023 - 09/2002
18	Leukemia 01/2024 - 02/2004
16	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2023 - 04/2002
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 11/2002
15	Chromosome Aberrations (Chromosome Abnormalities) 11/2021 - 01/2007
15	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 05/2002
13	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 11/2002
10	Residual Neoplasm 04/2024 - 02/2002
10	Multiple Myeloma 12/2023 - 09/2004
10	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2023 - 11/2002
10	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 12/2010
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 05/2002
8	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2017 - 11/2002
8	Genetic Translocation (Chromosomal Translocation) 10/2015 - 04/2002
7	Philadelphia Chromosome 01/2019 - 11/2010
7	Acute Promyelocytic Leukemia 01/2015 - 03/2004
6	Lymphadenopathy 03/2024 - 02/2002
6	Primary Myelofibrosis (Myelosclerosis) 02/2022 - 07/2004
6	Eosinophilia 01/2021 - 05/2003
6	Carcinoma (Carcinomatosis) 01/2019 - 06/2005
6	Carcinogenesis 07/2013 - 03/2006
5	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2023 - 11/2002
5	Epstein-Barr Virus Infections 07/2022 - 08/2013
5	Blast Crisis (Blast Phase) 01/2021 - 03/2011
5	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 10/2009
5	Fibrosis (Cirrhosis) 01/2018 - 07/2004
4	Paraproteinemias (Monoclonal Gammopathy) 12/2023 - 02/2005
4	Castleman Disease (Castleman's Disease) 08/2023 - 06/2014
4	Plasmacytoma 02/2023 - 11/2002
4	Cytopenia 01/2020 - 03/2010

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
42	Rituximab (Mabthera)FDA Link 12/2023 - 02/2002
37	Anaplastic Lymphoma KinaseIBA 01/2021 - 09/2002
24	Cyclin D1IBA 01/2024 - 05/2002
24	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 03/2002
20	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2007
20	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 06/2008
18	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 03/2002
17	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 08/2002
15	Tyrosine Kinase InhibitorsIBA 12/2023 - 09/2011
15	ParaffinIBA 12/2023 - 02/2002
14	Prednisone (Sone)FDA LinkGeneric 12/2023 - 03/2002
14	AntigensIBA 01/2022 - 02/2002
13	Phosphotransferases (Kinase)IBA 12/2023 - 08/2004
13	Messenger RNA (mRNA)IBA 11/2023 - 05/2002
12	Formaldehyde (Formol)FDA Link 12/2023 - 09/2003
12	RNA (Ribonucleic Acid)IBA 09/2023 - 04/2004
12	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2013 - 04/2002
11	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2005
10	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 10/2005
10	AntibodiesIBA 10/2018 - 04/2004
10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 02/2002
9	Capsules (Microcapsules)IBA 06/2023 - 07/2012
9	CytokinesIBA 02/2023 - 11/2004
9	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2011
9	ParaproteinsIBA 12/2022 - 03/2002
9	Immunoglobulin M (IgM)IBA 08/2019 - 08/2003
8	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023 - 02/2009
8	Peroxidase (Myeloperoxidase)IBA 11/2022 - 08/2005
8	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 07/2004
7	NucleophosminIBA 04/2024 - 07/2006
7	NF-kappa B (NF-kB)IBA 11/2023 - 02/2004
7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2002
7	Pyridinolcarbamate (P23)IBA 11/2014 - 05/2002
6	Immunoglobulin G (IgG)IBA 01/2023 - 05/2016
6	LigandsIBA 07/2022 - 01/2006
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 03/2007
6	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021 - 09/2015
6	MicroRNAs (MicroRNA)IBA 06/2015 - 07/2011
6	fludarabineIBA 06/2012 - 02/2002
5	ibrutinibIBA 10/2022 - 01/2016
5	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 05/2015
5	Granzymes (Granzyme)IBA 04/2019 - 11/2012
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 01/2011
5	NucleotidesIBA 01/2017 - 02/2012
5	TOR Serine-Threonine KinasesIBA 12/2010 - 07/2006
4	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2016
4	Reticulin (Reticular Fiber)IBA 01/2018 - 07/2004
4	Transcription Factors (Transcription Factor)IBA 10/2017 - 06/2005

Therapy/Procedure

160	Therapeutics 04/2024 - 05/2002
52	Drug Therapy (Chemotherapy) 12/2023 - 02/2002
24	Breast Implants (Breast Implant) 03/2024 - 09/2009
19	Radiotherapy 01/2021 - 03/2002
17	Stem Cell Transplantation 01/2023 - 10/2006
6	Immunotherapy 01/2024 - 01/2018
6	Splenectomy 01/2017 - 04/2006
5	Aftercare (After-Treatment) 01/2020 - 01/2004
4	Hematopoietic Stem Cell Transplantation 02/2022 - 08/2014
4	Induction Chemotherapy 10/2018 - 05/2003